France vs United Arab Emirates: The number of people with susceptibility test result for rifampicin
France
17
in 2021
United Arab Emirates
23
in 2021
France rank
134th
United Arab Emirates rank
131st
The number of people with susceptibility test result for rifampicin over time
- France
- United Arab Emirates
How they compare
United Arab Emirates currently reports 23 against 17 in France, a difference of 6.
That makes United Arab Emirates's figure about 1.4 times France's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was France ahead.
France ranks 134th and United Arab Emirates ranks 131st of 155 countries.
Across the 2 decades both report, France averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | France | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,801 | 32 | 1,769 | France |
| 2020s | 18.5 | 26 | 7.5 | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, France or United Arab Emirates?
- United Arab Emirates, at 23 against 17 in France as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between France and United Arab Emirates?
- 6, with United Arab Emirates ahead.
- How many years of comparable data are there for France and United Arab Emirates?
- 5 years are reported by both, from 2017 to 2021.
- How do France and United Arab Emirates rank globally for the number of people with susceptibility test result for rifampicin?
- France ranks 134th and United Arab Emirates ranks 131st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.